Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06654661 · ClinicalTrials.gov registry record · NA

Utilization of a 3D Printed Mechanical Balancer During Total Knee Arthroplasty (TKA)

A NA study, sponsored by NYU Langone Health.

Not yet
Registry status
NA
Development phase
50
Enrollment target

NCT06654661: Clinical Trial NA study, sponsored by NYU Langone Health.

NCT06654661 is a NA study that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06654661, a NA study, has not yet begun recruiting, sponsored by NYU Langone Health.

NOT YET RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The aim of this study is to test a 3D-printed mechanical balancer in a clinical setting during surgery to further evaluate the utility of the device. This will be a pilot prospective study of 50 patients undergoing primary total knee arthroplasty. Surgeons will utilize the device intraoperatively in addition to the standard of care practices of mechanical balancing. It will not guide clinical decision making.

Primary Outcome

Measured using the 3D-printed mechanical knee balancer.

Interventions

  • DEVICE 3D-Printed Mechanical Balancer

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-06-01
Est. Completion 2027-06-01
Phase NA
NYU Langone Health

1,164 total trials

What is known before NCT06654661 opens enrollment

NCT06654661 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which 3D-Printed Mechanical Balancer is the first listed.

NCT06654661 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06654661 about?

NCT06654661 is a clinical study titled "Utilization of a 3D Printed Mechanical Balancer During Total Knee Arthroplasty (TKA)". The aim of this study is to test a 3D-printed mechanical balancer in a clinical setting during surgery to further evaluate the utility of the device. This will be a pilot prospective study of 50 patients undergoing primary total knee arthroplasty. Surgeons will utilize the device intraoperatively in...

What is the current status of trial NCT06654661?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-06-01. Estimated completion is 2027-06-01.

What interventions are being tested in trial NCT06654661?

The interventions under investigation include: 3D-Printed Mechanical Balancer (DEVICE).

Who is sponsoring clinical trial NCT06654661?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06654661's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06654661, the US trial registry maintained by the National Library of Medicine. NCT06654661 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.